Status:
COMPLETED
Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.
Lead Sponsor:
Hôpital NOVO
Conditions:
Plastic Surgery
Eligibility:
FEMALE
18-50 years
Brief Summary
Tranexamic acid (TXA), as an antifibrinolytic agent, has shown a tremendous interest in surgery by reducing blood loss ; but only few articles have been reported in the plastic surgery scope. The aim ...
Detailed Description
A total of forty participants were included in this case-control study over a fifteen months period. The participants were divided in two equal groups. The case group (TXA group) was treated with a da...
Eligibility Criteria
Inclusion
- Woman with Primary Breast Augmentation
Exclusion
- Past History of Thromboembolism
- Use of anticoagulant or platelet-inhibiting drugs
- Severe Co-morbidity (ASA III)
- Pre-pectoral Implant Pocket Location
- Breast lipofecting
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03364569
Start Date
November 1 2014
End Date
April 1 2016
Last Update
July 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.